Mercury induces cell cytotoxicity and oxidative stress and increases β- amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 231-236

  Olivieri, G ^a,b   Brack, Ch ^a,b   Muller Spahn F ^a   Stahelin H B ^c   Herrmann, M ^a   Renard, P ^f   Brockhaus, M ^d   Hock, C ^a,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Geriatrische Universitatsklinik   (Switzerland)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^f UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Amyloid; Melatonin; Mercury; Oxidative stress; SHSY5Y neuroblastoma cells; Tau

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; GLUTATHIONE PEROXIDASE; MELATONIN; MERCURY;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SECRETION;

AMYLOID BETA-PROTEIN; CELL SURVIVAL; DRUG COMBINATIONS; GLUTATHIONE; MELATONIN; MERCURIC CHLORIDE; NEUROBLASTOMA; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0033957486     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740231.x     Document Type: Article

References (32)

1. Bains J. S. and Shaw C. A. (1997) Neurodegenerative disorders in humans: the role of glutalhione in oxidative stress-mediated neuronal death. Bruin Res. Rev. 25, 335-358.
2. Behl C. (1997) Amyloid beta-peptide toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 290, 471-480.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Brockhaus M., Grunberg J., Rohrig S., Loetscher H., Wittenburg N., Baumeister R., Jacobsen H., and Haas C. (1998) Caspase mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 9, 1481-1486.
5. Burgering B. M. T. and Coffer P. J. (1995) Protein kinase B in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599-602.
6. Busciglio J., Lorenzo A., Yeh J., and Yankner B. A. (1995) Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
7. Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M., and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
8. Dobeli H., Draeger N., Huber G., Jakob P., Schmidt D., Seilheimer B., Stuber D., Wipf B., and Zulauf M. (1995) A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residues amyloid peptide. Biotechnology 13, 988-993.
9. Edstrom A. and Mattsson H. (1976) Inhibition and stimulation of rapid axonal transport in vitro by sulfhydryl blockers. Brain Res. 108, 381-395.
10. Ehmann W. D., Markesbery W. R., Alauddin M., Hossain T. I. M., and Brubaker E. H. (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 197-206.
11. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., and Floyd R. A. (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad Sci. USA 91, 3270-3274.
12. Herrmann M., Golombowski S., Kräuchi K., Frey P., Mourton-Gilles C., Hulette C., Rosenberg C., Müller-Spann F., and Hock C. (1999) ELISA-quantitation of phosphorylated tau-protein in the Alzheimer's disease brain. Eur. Neurol. (in press).
13. Hock C., Drasch G., Golombowski S., Müller-Spahn F., Willershausen-Zönnchen B., Schwarz P., Hock U., Growdon J. H., and Nitsch R. M. (1998) Increased blood mercury levels in patients with Alzheimer's disease. J. Neural Transm. 105, 59-68.
14. Kim K. S., Wen G. Y., Bancher C., Chen C. M. J., Sapienza V. J., Hong H., and Wisniewski H. M (1990) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122.
15. Limson J., Nyokong T., and Daya S. (1998) The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. J. Pineal Res. 24, 15-21.
16. Mandelkow E. M. and Mandelkow E. (1998) Tau in Alzheimer's disease. Trends Cell. Biol. 8, 425-427.
17. Martin G. M., Austad S. N., and Johnson T. E. (1996) Genetic analysis of aging: role of oxidative and environmental stresses. Nat. Genet. 13, 25-34.
18. Mattson M. P., Goodman Y., Luo H., Fu W., and Furukawa K. (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese Superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
19. Pappolla M. A., Sos M., Omar R. A., Bick R. J., Hickson-Bick D. L. M., Reiter R. J., Efthimiopoulos S., and Robakis N. K. (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer's amyloid peptide. J. Neurosci. 17, 1683-1690.
20. Pappolla M. A., Bozner P., Soto C., Shao H., Robakis N. K., Zagorski M., Frangione B., and Ghiso J. (1998) Inhibition of Alzheimer β-fibrillogenesis by melatonin. J. Biol. Chem. 273, 7185-7188.
21. Rajanna B., Chetty C. S., Rajanna S., Hall E., Fail S., and Yallapragada P. R. (1995) Modulation of protein kinase C by heavy metals. Toxicol. Lett. 81, 197-203.
22. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-McLachlan D. R., Alberts M. J., et al. (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
23. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease Annu. Rev. Cell Biol. 10, 373-403.
24. Song W. and Lahiri D. K. (1997) Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12. J. Mol Neurosci. 9, 75-92.
25. Sorbi S., Nacmias B., Forleo P., Piacentini S., and Amaducci L. (1993) APP717 and Alzheimer's disease in Italy. Nat. Genet. 4, 10.
26. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., and Imahori K. (1996) Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidylinositol 3-kinase and the activation of tau protein kinase I glycogen synthase kinase-3β. Neurosci. Lett. 203, 33-36.
27. Tanzi R. E., Kovacs D. M., Kim T. W., Moir R. D., Guenette S. Y., and Wasco W. (1996) The presenilin genes and their role in early onset familial Alzheimer's disease. Alzheimers Dis. Rev. 1, 91-98.
28. Thompson C. M., Markesbery W. R., Ehmann W. D., Mao Y. X., and Vance D. E. (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1-8.
29. Toborek M. and Hennig B. (1994) Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am. J. Clin. Nutr. 59, 60-65.
30. Todoroki S., Yamaguchi M., Cho S., and Sumikawa K. (1998) Molecular mechanisms involved in the antioxidant effect of melatonin. (Abstr.) Anesthesiology 89, A204.
31. van Duijn C. M., de Knijfif P., Wehnert A., de Voecht J., Bronzova J. B., Havekes L. M., Hofman A., and van Broeckhoven C. (1995) The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann. Neurol. 37, 605-610.
32. +-induced oxidative injury by deprenyl (sele-giline), U-78517F and DMSO. Trends Clin. Neuropharmacol. 8, 187-188.